Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

What should be the HPV vaccine strategy for India?

Choosing Wisely: Value added cancer care for India

15 - 16 Oct 2019

Published: 7 Nov 2019

Views: 1809

Rating:

Save

Dr Rengaswamy Sankaranarayanan - WHO-IARC, Lyon, France

Dr Rengaswamy Sankaranarayanan presents a talk on 'What should be the HPV vaccine strategy for India?' at the Choosing wisely: Value Added Cancer Care for India event in New Delhi.

Related Videos

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network

Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA

Hammamet Declaration on Oncogenetics in Africa: African Oncogenetics Network ( Dr Timothy Rebbeck - Dana-Farber Cancer Institute, Boston, USA )

Prostate cancer

Dr Alison Tree - Institute of Cancer Research, London, UK

Prostate cancer ( Dr Alison Tree - Institute of Cancer Research, London, UK )

Rectal cancer

Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada

Rectal cancer ( Dr Rebecca Wong - Princess Margaret Cancer Center, Toronto, Canada )

Breast cancer

Dr Sofia Rivera - Gustave Roussy, Villejuif, France

Breast cancer ( Dr Sofia Rivera - Gustave Roussy, Villejuif, France )

Cancer advocacy and fundraising in Nigeria

Dr Zainab Shinkafi-Bagudu - Founder, Medicaid Cancer Foundation

Cancer advocacy and fundraising in Nigeria ( Dr Zainab Shinkafi-Bagudu - Founder, Medicaid Cancer Foundation )

ASCO's strategic plan for cancer care in LMICs

Dr Lynn Schuchter - President, American Society of Clinical Oncology (ASCO), USA

ASCO's strategic plan for cancer care in LMICs ( Dr Lynn Schuchter - President, American Society of Clinical Oncology (ASCO), USA )

The genomics of cancer in Africa

Prof Solomon Rotimi - Covenant University, Ota, Nigeria

The genomics of cancer in Africa ( Prof Solomon Rotimi - Covenant University, Ota, Nigeria )

Gender inequity in ovarian cancer research in resource limited settings

Dr Khalid El Bairi - Mohamed First University, Oujda, Morocco

Gender inequity in ovarian cancer research in resource limited settings ( Dr Khalid El Bairi - Mohamed First University, Oujda, Morocco )

Synthetic biology and precision medicine in blood and gynaecological cancers

Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa

Synthetic biology and precision medicine in blood and gynaecological cancers ( Dr Mutsa Takundwa - Council for Scientific and Industrial Research, Pretoria, South Africa )

More from ecancer